We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NIH Expands Trials of Convalescent Plasma for COVID-19
NIH Expands Trials of Convalescent Plasma for COVID-19
The National Institutes of Health (NIH) yesterday announced the expansion of two late-stage trials of convalescent plasma in the wake of the FDA’s Emergency Use Authorization (EUA) for the investigational COVID-19 treatment.